These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35786616)

  • 21. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
    Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
    World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
    Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
    DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer.
    Koushik A; Tranah GJ; Ma J; Stampfer MJ; Sesso HD; Fuchs CS; Giovannucci EL; Hunter DJ
    Int J Cancer; 2006 Oct; 119(8):1863-8. PubMed ID: 16721787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
    Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
    Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.
    Carvalho RM; Pinto GR; Yoshioka FK; Lima PD; Souza CR; Guimarães AC; Lamarão LM; Rey JA; Burbano RR
    J Neurooncol; 2012 Oct; 110(1):49-57. PubMed ID: 22886512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis.
    Dahabreh IJ; Linardou H; Bouzika P; Varvarigou V; Murray S
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1840-7. PubMed ID: 20615891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients.
    Nairuz T; Bushra YU; Kabir Y
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3809-3815. PubMed ID: 34967559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
    Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
    Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
    Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
    Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
    Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
    BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
    Ye J; Li XF; Wang YD; Yuan Y
    PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.
    Cardoso YMN; Resque RL; Yoshio D; B Miranda AR; Secco M; Do N Rodrigues AS
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):157-162. PubMed ID: 36708564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Liu ZH; Bao ED
    Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Wang JJ; Zheng Y; Sun L; Wang L; Yu PB; Dong JH; Zhang L; Xu J; Shi W; Ren YC
    Mol Biol Rep; 2011 Nov; 38(8):4847-53. PubMed ID: 21140221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
    Dong Z; Zheng L; Liu W; Wang C
    Cancer Manag Res; 2018; 10():1341-1349. PubMed ID: 29872345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
    Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
    Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.
    Yoneda T; Kuboyama A; Kato K; Ohgami T; Okamoto K; Saito T; Wake N
    Oncol Rep; 2013 Jul; 30(1):25-34. PubMed ID: 23624782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
    Khan MS; Pandith AA; Masoodi SR; Khan SH; Rather TA; Andrabi KI; Mudassar S
    Cancer Biomark; 2015; 15(4):459-65. PubMed ID: 25835179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma.
    Elsaid A; Zahran R; Elshazli R; El-Sayed A; Abou Samra M; El-Tarapely F; Abdel-Malak C
    Arch Physiol Biochem; 2019 Jul; 125(3):255-262. PubMed ID: 29560751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.